Dan Baker is a physician-scientist turned biotech founder who spent two decades at Johnson & Johnson's Janssen division helping bring immunology blockbusters Remicade, Simponi and Stelara to patients, before launching Brisbane-based Kira Biotech in 2019 as its founding CEO. Kira is developing KB312, a first-in-class antibody designed to selectively retrain the immune system rather than broadly suppress it, aimed at autoimmune diseases such as rheumatoid arthritis, lupus and type 1 diabetes. A rheumatologist who taught at the University of Pennsylvania for 18 years, Baker also advises drug-development organisations and serves as a healthcare venture partner.
SamaCare is a San Francisco-based healthcare technology company that runs the leading medical-benefit prior authorization platform for specialty medications. Its cloud-based, AI-assisted software replaces the fax-and-phone paperwork that delays patients from receiving life-changing biologics, automating submission, tracking, benefit verification, and enrollment across major US payers. The platform serves specialty practices in retina, oncology, neurology, and rheumatology, plus pharmaceutical manufacturers who use SamaCare's real-time data to improve patient access.
Juno Medical is a tech-enabled, family-first medical practice that combines modern clinics with a digital patient platform to deliver primary care, pediatrics, women's health, same-day care, mental health, and more. Founded in 2020 by physician Akili Hinson, MD, Juno builds in historically underserved neighborhoods and prices care transparently for families who fall between concierge membership clinics and Medicaid/Medicare-focused providers - what it calls the 99%.
House Rx is a San Francisco-based healthcare technology company that partners with specialty clinics to enable medically integrated dispensing (MID) - a model where physicians, pharmacists, nurses, and care coordinators work together as one unified team. Founded in 2021 by Flatiron Health veterans Ogi Kavazovic and Tesh Khullar, the company builds AI-enabled pharmacy management software that keeps specialty medications dispensed at the point of care, cutting average time-to-therapy from 15.5 days to 3.5 days and achieving 95% medication adherence. With $100M raised across Seed, Series A, and Series B rounds, House Rx serves 80 clinic sites, 1,000+ providers, and nearly 61,000 patients, processing approximately $1.5 billion in specialty prescriptions annually.